Multiple endocrine neoplasia 1D44.8

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 11.12.2022

Dieser Artikel auf Deutsch

Synonym(s)

Endocrine adenomatosis multiple; endocrine polyadenomatosis; familial polyadenomatosis; MEA type I; MEN-1 syndrome; MEN I, MEN 1; MEN-I Syndrome; MEN Type I; Multiple endocrine adenomatosis; Multiple endocrine adenomatosis type I; multiple endocrine neoplasia type 1; Polyadenomatosis familial; Polyglandular adenoma syndrome; wormer syndrome

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Erdheim, 1903; Wermer, 1954

DefinitionThis section has been translated automatically.

Disease pattern belonging to the multiple endocrine neoplasms with combination of peptic ulcers, hyperplastic or tumorous changes of the endocrine pancreas(insulinoma, gastrinoma, glucagonoma, VIPoma), parathyroid gland (mostly adenomatous hyperplasia), anterior pituitary gland (mostly Cushing's syndrome) and possibly thyroid gland (follicular or papillary carcinoma). Frequent comnoinaiton with multiple lipomas.

Occurrence/EpidemiologyThis section has been translated automatically.

Panethnic. Prevalence: 0.5-1/100.000 inhabitants/year.

EtiopathogenesisThis section has been translated automatically.

Autosomal dominant inheritance. Mutation of the MEN1 gene (menin gene), a tumor suppressor gene mapped to gene locus 11q13, with consecutive loss of an autosome in the tumor with hemizygosity.

ManifestationThis section has been translated automatically.

First symptoms appear during puberty or in adulthood (20.-50. LJ). Women are affected about twice as often as men.

Clinical featuresThis section has been translated automatically.

Zollinger-Ellison syndrome with diarrhea. Increased gastrin secretion, gastric ulcers (gastrinomas in 60% of pat.), hypertrophic gastropathy Ménétrier.

Primary hyperparathyroidism: parathyroid hormone increased (in 90-97% of pat.).

Hyperinsulinism (20% insulinomas) or pancreatic neoplasms (in 30-80% of cases).

Pituitary tumors (15-50%).

Struma nodosa, multiple lipomas (also liposarcomas) in the subcutaneous region (not obligatory).

Angiofibromas, bronchial adenomas (not obligate), colonic polyposis (not obligate, rare).

Progression/forecastThis section has been translated automatically.

Limited life expectancy (exitus lethalis in 50% of patients around the age of 50).

LiteratureThis section has been translated automatically.

  1. Berglund G et al (2003) Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1). Fam Cancer 2: 27-33
  2. Brandi ML, Marx SJ, Aurbach GD, Fitzpatrick LA (1987) Familial multiple endocrine neoplasia type I: a new look on pathophysiology. Endocrinol Rev 8: 391-405
  3. Doherty GM et al (2003) Multiple endocrine neoplasia type 1: duodenopancreatic tumours. J Internal Med 253: 590-598
  4. Norton JA et al (2003) Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surg Oncol 12: 145-151
  5. Wermer P (1954) Genetic aspect of adenomatosis of endocrinic glands. On J Med 16: 363-371

Authors

Last updated on: 11.12.2022

Author: Prof. Dr. med. Peter Altmeyer